Table 4 Number (percentage) of patients with adverse event in the study population
|  | Sinovial H-L Group (n = 55) | Triamcinolone Group (n = 45) |
|---|---|---|
Joint pain | 2 (3.63%) | 2 (4.44%) |
Joint swelling | 0 (0%) | 1 (2.22%) |
Injection site haematoma | 0 (0%) | 1 (2.22%) |
Total number of patients with adverse event | 2 (3.63%) | 4 (8.88%) |